COV 97.93 Covidien Plc. $COV Hit a 52 week high of 98.14

New Post Public Reply Private Reply Replies (0) Message Board

Nov 19, 2014 at 11:01 AM

COV 97.93 Covidien Plc. $COV Hit a 52 week high of 98.14 Closing the day 09:45 at 97.93 -0.16 -0.16% With a day low of 97.34 and a total volume of 124,948.

COV Recent Posts: http://investorshangout.com/Covidien-Plc-COV-50596/

COV Covidien Plc. Recent Headline News

Uptrend Call Working As Covidien Stock Rises 36.0% (COV)
Comtex SmarTrend(R) - 14 mins ago
SmarTrend identified an Uptrend for Covidien (NYSE:COV) on May 12th, 2014 at $72.16. In approximately 6 months, Covidien has returned 35.96% as of today's recent price of $98.11.
COV: 97.91 (-0.18)

Stock Market News for November 19, 2014 - Market News
Zacks Equity Research - Zacks Investment Research - 50 mins ago
Rally in healthcare stocks and easing global growth worries boosted benchmarks to finish in the green on Tuesday
URBN: 28.68 (-0.11), AGN: 213.15 (-0.22), HD: 96.93 (+0.95), ACT: 266.58 (-3.02), GILD: 101.77 (-1.94), PFE: 30.44 (-0.15), COV: 97.91 (-0.18), ALXN: 192.47 (+0.10)

Announcement under Irish Takeover Rules Relevant Securities in Issue - November 19, 2014
Business Wire - 1 hr 19 mins ago
In accordance with Rule 2.10 of the Irish Takeover Rules, Covidien plc (NYSE: COV) (the "Company"

confirms that, as of the close of business on November 18, 2014, the Company's issued share capital, excluding treasury shares, consisted of 452,731,347 ordinary shares, par value US$0.20 per share (the "Ordinary Shares"

. The International Securities Identification Number (ISIN) of the Ordinary Shares is IE00B68SQD29.
COV: 97.91 (-0.18)

Medtronic digesting purchases
at Investor's Business Daily - Tue Nov 18, 5:43PM CST
The medical device giant delivered a solid fiscal Q2 report as EPS rose 5% to 96 cents, in line with estimates, on a 4% hike in revenue to $3.67 bil, also meeting estimates. Medtronic (MDT), which is digesting several small acquisitions, said it's...
MDT: 71.88 (-0.59), COV: 97.91 (-0.18)

SmarTrend Watching for Potential Pullback in Shares of Covidien After 3.68% Gain
Comtex SmarTrend(R) - Tue Nov 18, 3:53PM CST
Covidien (NYSE:COV) traded in a range yesterday that spanned from a low of $94.66 to a high of $98.32. Yesterday, the shares gained 3.7%, which took the trading range above the 3-day high of $94.90 on volume of 4.7 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
COV: 97.91 (-0.18)

Look for Shares of Covidien to Potentially Pullback after Yesterday's 3.68% Rise
Comtex SmarTrend(R) - Tue Nov 18, 3:53PM CST
Covidien (NYSE:COV) traded in a range yesterday that spanned from a low of $94.66 to a high of $98.32. Yesterday, the shares gained 3.7%, which took the trading range above the 3-day high of $94.90 on volume of 4.7 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
COV: 97.91 (-0.18)

Medtronic (MDT) Posts In Line Earnings, Revenues Beat in Q2 - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Nov 18, 11:21AM CST
Medtronic Inc.'s (MDT) second-quarter fiscal 2015 adjusted earnings per share (EPS) came in at 96 cents.
BSX: 13.56 (-0.12), MDT: 71.88 (-0.59), ABAX: 54.36 (-0.25), COV: 97.91 (-0.18)

See Why Medtronic Stock Is Surging Today
Sure Dividend - at Seeking Alpha - Tue Nov 18, 10:15AM CST

MDT: 71.88 (-0.59), COV: 97.91 (-0.18)

Medtronic Earnings In Line; Sales Guidance Up
at Investor's Business Daily - Tue Nov 18, 9:55AM CST
Medical-device giant Medtronic (MDT) early Tuesday delivered a solid quarter and modestly bullish revenue guidance as it digests several small acquisitions and prepares for a huge one. Medtronic was up 3.5% in early trading in the stock market today,...
MDT: 71.88 (-0.59), COV: 97.91 (-0.18), STJ: 64.47 (-0.48)

InsiderInsights.com Daily Round Up 11/17/14: SFM, INTX, GNRC, GSAT
InsiderInsights - at Seeking Alpha - Tue Nov 18, 5:55AM CST

HCOM: 26.31 (-0.61), IPHI: 14.31 (-0.30), JBHT: 79.75 (-0.18), COV: 97.91 (-0.18), OPHT: 40.29 (-0.89), COP: 71.43 (-0.24), SFM: 31.44 (+0.03), GOOG: 532.11 (-2.92), GSAT: 2.66 (+0.11), STAY: 18.29 (-0.23), ZOES: 32.68 (-0.29), INTX: 3.76 (-0.08), GNRC: 43.08 (-0.75), HZNP: 12.68 (-0.17), TRUE: 17.55 (+0.13)

Covidien's Test Data Positive for VenaSeal Closure System - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Nov 17, 5:10PM CST
Covidien plc (COV) recently announced six-month results from the VeClose pivotal study, which was carried out to evaluate the safety and efficiency of the VenaSeal closure system, a treatment option for chronic venous disorders.
JNJ: 108.28 (-0.55), BDX: 130.27 (-0.67), BCR: 166.12 (-1.24), COV: 97.91 (-0.18)

Medtronic and Covidien Shareholder Meetings Scheduled for January 6, 2015
Thomson Reuters ONE - Mon Nov 17, 11:30AM CST

MDT: 71.88 (-0.59), COV: 97.91 (-0.18)

Six Month Results of VeClose Study Demonstrate Safety, Effectiveness of the VenaSeal(TM) Closure System
Business Wire - Thu Nov 13, 5:00PM CST
Covidien plc (NYSE:COV) today announced the six-month results of the VeClose pivotal study, which demonstrated the safety and effectiveness of the VenaSeal(TM) closure system* in patients with chronic venous insufficiency (CVI) having symptomatic reflux in the great saphenous vein. The results were presented at American College of Phlebology Annual Congress (ACP 2014) in Phoenix, Ariz.
COV: 97.91 (-0.18)

Form 8.1 - Covidien
Business Wire - Thu Nov 13, 10:17AM CST
Covidien plc:
COV: 97.91 (-0.18)

Insider Trading Alert - CTSH, PSEC And COV Traded By Insiders
at The Street - Thu Nov 13, 9:15AM CST
Stocks with insider trader activity include CTSH, PSEC and COV
COV: 97.91 (-0.18), CTSH: 52.02 (-0.72), PSEC: 9.61 (-0.07)

Covidien Shares Up 28.9% Since SmarTrend's Buy Recommendation (COV)
Comtex SmarTrend(R) - Wed Nov 12, 9:16AM CST
SmarTrend identified an Uptrend for Covidien (NYSE:COV) on May 12th, 2014 at $72.16. In approximately 6 months, Covidien has returned 28.91% as of today's recent price of $93.02.
COV: 97.91 (-0.18)

Wall Street Breakfast: Global Banks Fined $3.4B In Forex Probe
Wall Street Breakfast - Seeking Alpha - Wed Nov 12, 5:30AM CST
Economy Japanese stocks scaled seven-year highs this morning on further speculation that Prime Minister Shinzo Abe will postpone a planned sales tax hike and call a general election for December. The Sankei newspaper reported that Abe would...
VRX: 142.17 (+0.23), MDT: 71.88 (-0.59), C: 53.46 (-0.35), WMT: 84.55 (+0.76), RBS: 12.02 (+0.05), UBS: 17.51 (-0.01), NOK: 7.74 (-0.19), YHOO: 50.45 (-1.30), PBR: 9.38 (-0.04), SPY: 204.43 (-1.12), SAP: 68.62 (+0.02), EBAY: 54.42 (-0.96), JPM: 60.20 (-0.33), BHP: 55.97 (-1.57), AAPL: 114.37 (-1.10), BCS: 14.81 (-0.07), FRM: 6.35 (-0.15), COV: 97.91 (-0.18), HSBC: 49.58 (-0.36), FRGI: 56.11 (+0.09), ZTS: 43.87 (-0.32), DLA: 10.50 (-0.01), QQQ: 102.91 (-0.77), AOL: 45.11 (-0.59), BABA: 107.77 (-3.04)

Medtronic submits concessions for $43B Covidien takeover
Seeking Alpha - at Seeking Alpha - Wed Nov 12, 3:53AM CST

MDT: 71.88 (-0.59), COV: 97.91 (-0.18)

Insider Trading Alert - TSLA, COV And AKS Traded By Insiders
at The Street - Tue Nov 11, 9:08AM CST
Stocks with insider trader activity include TSLA, COV and AKS
TSLA: 247.63 (-10.07), COV: 97.91 (-0.18), AKS: 6.20 (-0.19)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Eric Dalton: Redefining Homecare with Vision and Strategy

What's Behind Eric Dalton's Continued Recognition? Now, if you told me a healthcare leader’s named 'Visionary of the Year' twice in a row, my first thought isn't 'stretch goals' but 'show me the goods.' And that’s precisely what Eric J. Dalton has done. The Vice President at Angels on Call Homecare isn't just tooting his own horn; he's building a damn symphony in the...

LG Energy Sparks Global Innovation with BIC 2026

Innovating Beyond Boundaries with LG Energy The world of battery tech is on fire, and LG Energy Solution is fanning the flames with their Battery Innovation Contest 2026 (BIC 2026). From October 29 to December 6, 2026, universities and research hives across the globe are being beckoned to pour their battery brilliance into this contest. These aren't just any research...

Clip Expands Horizons with Pulpos Acquisition, New Board Member

Clip's Strategic Move with Pulpos Clip just laid down a serious marker in the digital payment world by snagging Pulpos, a firm that’s got its claws deep into AI-driven business management software. This move isn't just some fancy headline. It's a real, grounded step in expanding Clip's ecosystem to bolster the backbone of Mexico's economy: small and medium-sized...

Genefluence Launches Rapid UTI PCR Test at Chelsea Hospital

There's a fresh breeze blowing through the dusty corridors of healthcare, shaking things up for the better. You see, Genefluence, the brainchild of Professor Chris Toumazou, isn't just throwing a bunch of tech jargon around—it's setting the stage for a much-needed shake-up in how we handle urinary tract infections (UTIs) and, believe me, it couldn’t have come sooner....

Honeywell Aerospace Posts Solid Q3, Raises Guidance

Honeywell Aerospace Surprises with Strong Third Quarter In a world where numbers are often as slippery as a greased pig, Honeywell Aerospace (NASDAQ:HONA) has managed to pin down a surprisingly robust third quarter. Let’s break it down: they’ve claimed sales of a cool $4.6 billion, reflecting a 2% bump both in reported and organic revenue from the previous year, and...

Oracle's Bold Vision: Targeting $225B Revenue by 2030

Oracle Lays Down a Bold Gauntlet Oracle Corporation (NYSE: ORCL) sure knows how to draw the spotlight. With their recent Investor Day in Vegas, they've laid out ambitions that could make even the most seasoned Wall Streeter spit out their coffee. Who would've thought they'd be betting on a whopping $225 billion in revenue by FY30? That's supposed to be a more than 35%...

2026 Global Ocean Forum Unveils Key Marine Strategies

Riding the Waves in Qingdao It ain't every day that a talk-fest dedicated to oceans gets my attention, but when the Global Ocean Development Forum plants its flag in Qingdao, even I sit up. We're talking about some real fireworks in the marine economy sector with this gig's '1+1+4+8' framework. Now, before you scratch your head on the bingo numbers—it's the opening...

TransCode Pursues Strategic Moves for TTX-MC138 Value

A New Chapter for TransCode? Every once in a while, you find companies taking bold steps that make the market look twice. Today, that’s TransCode Therapeutics (NASDAQ: RNAZ) putting their chips on the table, determined to find the best route forward for their oncology efforts. Now, I’ve seen outfits talk plans without substance, but getting Tungsten Advisors on board...

Firehawk Defense Secures $150M, Valuation Hits $1.4B

Firehawk Defense Lands Major Funding Think about it—Firehawk Defense, a gutsy Dallas-based new-kid-on-the-block, just snagged a whopping $150 million in fresh funding. The news? Their valuation's now sitting pretty at $1.4 billion. Not peanuts, by any means. For a company in the artillery game, that's a blast of an announcement. They're predicting they'll become the big...

Step into Fear: Dead by Daylight in Moreno Valley

Immersive Horror in Moreno Valley Walking straight into the fog of your nightmares isn't for the faint-hearted, but that's the kind of thrill the Moreno Valley Museum & ArtSpace is serving up with its new Dead by Daylight Immersive Experience. Kicking off just in time for Halloween on October 30, this isn't your average stroll in a museum—it's a heart-pounding,...